1 / 23

Computational Toxicology and Virtual Development in Drug Design

Computational Toxicology and Virtual Development in Drug Design. Dale E. Johnson, Pharm.D., Ph.D. Chief Scientific Officer ddplatform LLC. The “Problem” in pharmaceutical R&D. The “Solution” for R&D . ~ $700 MM and over 10 years to develop novel drug

omer
Download Presentation

Computational Toxicology and Virtual Development in Drug Design

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Computational Toxicology and Virtual Development in Drug Design Dale E. Johnson, Pharm.D., Ph.D. Chief Scientific Officer ddplatform LLC

  2. The “Problem” in pharmaceutical R&D The “Solution” for R&D • ~ $700 MM and over 10 years to develop novel drug • Approximately 75% of overall R&D cost attributed to failures • Identify/eliminate problematic drugs early • Design desirable properties into drugs

  3. Drug Discovery: the hunting process where is toxicology today? From: Rosamond and Allsop, Science 287, 1973 (2000)

  4. Early toxicology at the Lead Optimization Step: still a high failure rate – high cost to R&D ADME, PK, TOX Lead optimization Secondary in vitro screening In vivo and mechanistic screens Lead selection Primary & secondary efficacy screening Chemical Libraries Chemical Libraries Development Candidate 65% Drop Out IND enabling studies Phase I, II

  5. The toxicology solution • Incorporate predictive toxicology concept throughout discovery & development • Design reduced toxicity into chemical libraries • Create expert systems to accelerate and increase success rate • Expert systems must be multi-disciplinary for real impact

  6. Major needs in Predictive Toxicology: Recent industry surveys • Predictive software with updated databases • Improved data mining capabilities • Enhanced in vitro mechanistic screens • Ready access to human hepatocytes and other cells • Relevant application of new technologies ie. toxicogenomics

  7. Major needs in Predictive Toxicology: Recent industry surveys • Predictive software with updated databases • Improved data mining capabilities • Enhanced in vitro mechanistic screens • Ready access to human hepatocytes and other cells • Relevant application of new technologies ie. toxicogenomics

  8. Missing elements in the toolbox • Quality data from controlled sources • Newly created database(s) using “pharmaceutical” chemical space • Multi-disciplinary chem-tox Information / decision tools • Data mining via “med chem building blocks” • Flexibilityto incorporate all data from internal and external sources • Web-based, platform independent

  9. LeadScopeTM Technology • Structural analysis based on familiar structural features • Powerful graphical representations and dynamic querying • Refine structure alerts to reflect new assay results • Statistically test structural hypotheses

  10. RTECS database & liver toxicity • ~7000 compounds with liver toxicity codes • Expert conversion to grades (risk) • Ordinal ranks using severity of findings, dose, regimen, species • Create 1o liver tox – chemical space • Data mining with ToxScopeTM: correlations between chemical structure and liver toxicity

  11. Feature Hierarchy Graphic Panel Filter Panel Information Windows

  12. Portion of the Heterocycles hierarchy showing 3 levels of the pyridine subhierarchy Selected subset of compounds containing a pyridine substructure with an acyclic alkenyl group in the 2-position Subset contains 2 compounds

  13. Each structure feature in the hierarchy is defined as a substructure search query Structural definition atom and bond restrictions

  14. Compounds containing a pyridine, 2-(alkenyl, acyc) substructure

  15. Uncovering bias in chemical space within data sets • Detect + and – coverage within a desired chemical space • Understand decision errors that can be introduced with biased space

  16. Structural alerts • Can rapidly find structural alerts • Can view new libraries in relation to structural alerts • Can evaluate impact of alert on optimization scheme

  17. RTECS grade 5 only

  18. ToxScopeTM Components • LeadScopeTM Enterprise Technology • Several public or commercial databases • New databases using “pharmaceutical" chemical space • New specific organ toxicity database • Structural alerts • Continual updates on target organs

  19. Conclusion “… an in silico revolution is emerging that will alter the conduct of early drug development in the future.” “Preclinical safety must transition from an experimental-based process into a knowledge-based, predictive process, where experimentation is used primarily to confirm existing knowledge”

  20. Acknowledgements Grushenka Wolfgang, Co-author Julie Roberts Kevin Cross Bill Snyder Michael Crump Chris Freeman Jeff Miller Don Swartz Michael Murray Ilya Utkin Mark Balbes Wayne Johnson Zhicheng Li Allen Richon Yan Wang Paul Blower Limin Yu Glenn Myatt Sighle Brackman Emily Johnson Lisa Balbes

More Related